Delivery Order SPE2DB24D8003-SPE2DB25FJUPK

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,229.69 firm fixed price delivery order is for the supply of 100 units of the medication lisdexamfetamine 60 mg capsules. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,000.64, is for the delivery of 4566862011 - LISDEXAMFETAMINE 40 MG CAPSULE 100S to support U.S. Armed Forces medical operations. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. It is not a set-aside contract. Dakota Drug, Inc. is a key supplier for the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,333.36 firm fixed-price contract is for the delivery of 4,568,201,145 units of Lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of May 12, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a contract number of SPE2DB24D8002|SPE2DB25FJNDD, is for the delivery of 4,567,235 units of 50 mg lisdexamfetamine capsules. The contract has a firm fixed-price delivery order type with a ceiling value of $1,350.58 and a completion date of February 12, 2025. Dakota Drug, Inc. is also the holder of a significant single-award Indefinite...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota, by the Defense Logistics Agency (DLA). The award, valued at $2,465.64, is a delivery order under the DLA's Troop Support Medical's ECAT Generation V Program, which seeks to provide commercial medical equipment, accessories, consumables, and medical simulation equipment used by medical professionals. The contract allows Dakota Drug, Inc. to efficiently deliver a...
This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets in 100-count packages to the Defense Logistics Agency (DLA). The $3,362.34 firm fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The award is not set-aside and has an ultimate completion date of May 28, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the...
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,254.00 firm fixed-price delivery order is for the supply of 4,566,177,751 units of Dexmethylphenidate ER 5 mg capsules. The award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and runs through December 31, 2025. It is part of the DLA Troop Support Medical's ECAT Generation V Program, which seeks proposals for commercial medical equipment, accessories, consumables, and medical simulation...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract falls under the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. Through this single-award IDC, Dakota Drug, Inc. will provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of lisdexamfetamine 50 mg capsules, a pharmaceutical product. The contract has a ceiling value of $2,326.86 and a completion date of December 18, 2024. This contract is not set aside for any special designation. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJUPK
    Delivery Order

This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business in Anoka, Minnesota, is a Delivery Order valued at $1,222.01. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the delivery of LISDEXAMFETAMINE 10 MG CAPSULE 100S. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract is not set-aside and has an ultimate completion date of June 12, 2025.

Generated 9/10/25, 9:59 AM